| Symbol |
Name |
|
ACAD9
|
acyl-CoA dehydrogenase family, member 9
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BPI
|
bactericidal/permeability-increasing protein
|
|
CACNA2D1
|
calcium channel, voltage-dependent, alpha 2/delta subunit 1
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CCND1
|
cyclin D1
|
|
CORT
|
cortistatin
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
DSCAM
|
Down syndrome cell adhesion molecule
|
|
DSG1
|
desmoglein 1
|
|
DSG2
|
desmoglein 2
|
|
DSG3
|
desmoglein 3
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
FBN1
|
fibrillin 1
|
|
FUS
|
FUS RNA binding protein
|
|
FXN
|
frataxin
|
|
GAL
|
galanin/GMAP prepropeptide
|
|
GLI1
|
GLI family zinc finger 1
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
HPSE
|
heparanase
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL31RA
|
interleukin 31 receptor A
|
|
ITGA9
|
integrin, alpha 9
|
|
KRT14
|
keratin 14, type I
|
|
KRT16
|
keratin 16, type I
|
|
KRT71
|
keratin 71, type II
|
|
KRT73
|
keratin 73, type II
|
|
KRT74
|
keratin 74, type II
|
|
KRT75
|
keratin 75, type II
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
MAFA
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog A
|
|
MIR19A
|
microRNA 19a
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPZ
|
myelin protein zero
|
|
MRGPRX2
|
MAS-related GPR, member X2
|
|
MYO10
|
myosin X
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NPPA
|
natriuretic peptide A
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
P2RX3
|
purinergic receptor P2X, ligand gated ion channel, 3
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDPN
|
podoplanin
|
|
PGF
|
placental growth factor
|
|
PRKCD
|
protein kinase C, delta
|
|
PTGIR
|
prostaglandin I2 (prostacyclin) receptor (IP)
|
|
S1PR3
|
sphingosine-1-phosphate receptor 3
|
|
SCN10A
|
sodium channel, voltage gated, type X alpha subunit
|
|
SCN8A
|
sodium channel, voltage gated, type VIII alpha subunit
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SLC22A5
|
solute carrier family 22 (organic cation/carnitine transporter), member 5
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SPON1
|
spondin 1, extracellular matrix protein
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TH
|
tyrosine hydroxylase
|
|
TLR3
|
toll-like receptor 3
|
|
TLR7
|
toll-like receptor 7
|
|
TLR9
|
toll-like receptor 9
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TRPV3
|
transient receptor potential cation channel, subfamily V, member 3
|
|
TTR
|
transthyretin
|
|
TXNRD1
|
thioredoxin reductase 1
|
|
UGT1A9
|
UDP glucuronosyltransferase 1 family, polypeptide A9
|
|
UTS2
|
urotensin 2
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
